Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation

Steroids

Volumn 74, Issue 12, 2009, Pages 971-977

  Sten, Taina ^a   Finel, Moshe ^a   Ask, Birgitta ^b   Rane, Anders ^b   Ekström, Lena ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Epitestosterone; T E ratio; Testosterone; UGT2B17 deletion

Indexed keywords

DICLOFENAC; DIMETHYL SULFOXIDE; DISODIUM HYDROGEN PHOSPHATE; EPITESTOSTERONE; FORMIC ACID; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A3; GLUCURONOSYLTRANSFERASE 1A4; GLUCURONOSYLTRANSFERASE 1A9; GLUCURONOSYLTRANSFERASE 2B7; IBUPROFEN; MAGNESIUM CHLORIDE; POTASSIUM DIHYDROGEN PHOSPHATE; RECOMBINANT ENZYME; TESTOSTERONE; TESTOSTERONE GLUCURONIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG GLUCURONIDATION; DRUG SENSITIVITY; ENZYME INHIBITION; GENOTYPE; HORMONE INHIBITION; HUMAN; HUMAN TISSUE; IC 50; LIVER MICROSOME METABOLISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; GENOTYPE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; IBUPROFEN; LIVER; MICROSOMES; RECOMBINANT PROTEINS; TESTOSTERONE;

EID: 69949175584     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.07.004     Document Type: Article

References (29)

1. King C., Tang W., Ngui J., Tephly T., and Braun M. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac. Toxicol Sci 61 (2001) 49-53
2. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40 (2000) 581-616
3. Mackenzie P.I., Bock K.W., Burchell B., Guillemette C., Ikushiro S., Iyanagi T., et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15 (2005) 677-685
4. Belanger A., Pelletier G., Labrie F., Barbier O., and Chouinard S. Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14 (2003) 473-479
5. Sten T., Bichlmaier I., Kuuranne T., Leinonen A., Yli-Kauhaluoma J., and Finel M. UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly. Drug Metab Dispos 37 (2009) 417-423
6. Jakobsson J., Ekström L., Inotsume N., Garle M., Lorentzon M., Ohlsson C., et al. Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab 91 (2006) 687-693
7. Bowalgaha K., Elliot D.J., Mackenzie P.I., Knights K.M., and Miners J.O. The glucuronidation of Delta4-3-Keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs): 6alpha- and 21-hydroxyprogesterone are selective substrates for UGT2B7. Drug Metab Dispos 35 (2007) 363-370
8. Coffman B.L., King C.D., Rios G.R., and Tephly T.R. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos 26 (1998) 73-77
9. Schulze J.J., Lorentzon M., Ohlsson C., Lundmark J., Roh H.K., Rane A., et al. Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes. Pharmacogenet Genomics 18 (2008) 477-485
10. Donike M., Bärwald K.-R., Klostermann K., Schänzer W., and Zimmermann J. Nachweis von exogenem testosteron (The detection of exogenous testosterone). In: Heck H., Hollmann W., Leisen H., and Rost R. (Eds). Sport: Leistung und Gesundheit (1983), Deutsche Ärtze-Verlag, Cologne 292-300
11. WADA. Reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids. Available at http://www.wada-ama.org/rtecontent/document/end_steroids_aug_04.pdf; 2004.
12. Schulze J.J., Lundmark J., Garle M., Skilving I., Ekström L., and Rane A. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation. J Clin Endocrinol Metab 93 (2008) 2500-2506
13. Sottas P.E., Baume N., Saudan C., Schweizer C., Kamber M., and Saugy M. Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio. Biostatistics 8 (2007) 285-296
14. Schulze J.J., Lundmark J., Garle M., Ekström L., Sottas P.E., and Rane A. Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests. Steroids (2008)
15. Kuehl G.E., Lampe J.W., Potter J.D., and Bigler J. Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos 33 (2005) 1027-1035
16. Alaranta A., Alaranta H., and Helenius I. Use of prescription drugs in athletes. Sports Med 38 (2008) 449-463
17. Davies N.M. Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet 34 (1998) 101-154
18. Jin C., Miners J.O., Lillywhite K.J., and Mackenzie P.I. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 264 (1993) 475-479
19. von Bahr C., Groth C.G., Jansson H., Lundgren G., Lind M., and Glaumann H. Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther 27 (1980) 711-725
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
21. Kurkela M., Garcia-Horsman J.A., Luukkanen L., Mörsky S., Taskinen J., Baumann M., et al. Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme. J Biol Chem 278 (2003) 3536-3544
22. Kurkela M., Patana A.S., Mackenzie P.I., Court M.H., Tate C.G., Hirvonen J., et al. Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6. Pharmacogenet Genomics 17 (2007) 115-126
23. Narayanan R., LeDuc B., and Williams D.A. Determination of the kinetics of rat UDP-glucuronosyltransferases (UGTs) in liver and intestine using HPLC. J Pharm Biomed Anal 22 (2000) 527-540
24. Kuuranne T., Kurkela M., Thevis M., Schänzer W., Finel M., and Kostiainen R. Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 31 (2003) 1117-1124
25. Cortes A., Cascante M., Cardenas M.L., and Cornish-Bowden A. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J 357 (2001) 263-268
26. Mano Y., Usui T., and Kamimura H. Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes. Eur J Clin Pharmacol 63 (2007) 211-216
27. Uchaipichat V., Mackenzie P.I., Guo X.H., Gardner-Stephen D., Galetin A., Houston J.B., et al. Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos 32 (2004) 413-423
28. Turgeon D., Carrier J.S., Chouinard S., and Belanger A. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Drug Metab Dispos 31 (2003) 670-676
29. Itäaho K., Mackenzie P.I., Ikushiro S., Miners J.O., and Finel M. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases. Drug Metab Dispos 36 (2008) 2307-2315